The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

5 Aug 2022 17:43

RNS Number : 1584V
abrdn China Investment Company Ltd.
05 August 2022
 

05 August 2022

abrdn China Investment Company Limited ("ACIC" or the "Company")

LEI: 213800RIA1NX8DP4P938

 

PURCHASE OF OWN ORDINARY SHARES

On 5 August 2022, the Company purchased in the market 20,000 Ordinary shares at 574.840000 pence per share. These shares will be held in treasury.

Following the transaction, the Company's share capital comprises:

45,960,724 Issued Ordinary shares (excluding treasury shares)

16,212,223 Ordinary shares held in treasury

62,172,947 Issued Ordinary shares (including treasury shares)

The total number of Ordinary shares with voting rights in the Company is 45,960,724 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

Enquiries:

abrdn Fund Managers Limited (Alternative Investment Fund Manager to the Company)

Evan Bruce-Gardyne Tel +44 (0)7720 073216

UK Administration Agent

Sylvanus Cofie / Brian Smith Tel: +44 (0)20 3327 9720

Shore Capital & Corporate Limited (Financial adviser and broker to the Company)

Robert Finlay / Rose Ramsden Tel: +44 (0)20 7601 6115 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSRTIIEIIF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.